1-4 of 4
H. Goldschmidt, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Genetic Contribution to the Aetiology of Thalidomide Associated VTE.

Gareth J. Morgan, MD, PhD, David C. Johnson, BSc, John Crowley, PhD, John Shaughnessy, Jr., PhD, Pieter Sonneveld, MD, Brian Durie, MD, Christine Ramos, PhD, Brian G. Van Ness, PhD, Bart Barlogie, MD, Antje Hoering, PhD, Jeff Haessler, PhD, Dalsu Baris, MD, PhD, Michael Katz, BS, Vincent S. Rajkumar, MD, H. Goldschmidt, MD
Journal: Blood
Blood (2006) 108 (11): 246.
https://doi.org/10.1182/blood.V108.11.246.246
Published: 2006
Journal Articles

Uptake of New Therapeutics in the Treatment of Multiple Myeloma (MM) in Germany (GER) - Results from a Representative Multicentre Treatment Survey 2006.

Ralf Angermund, MD, W. Knauf, MD, M. Freund, MD, M. Nowrousian, MD, H. Einsele, MD, H. Goldschmidt, MD, W. Berdel, MD, W. Poenisch, MD, C. Straka, MD, L. Kellermann, H. Pliskat, PhD
Journal: Blood
Blood (2006) 108 (11): 5110.
https://doi.org/10.1182/blood.V108.11.5110.5110
Published: 2006
Journal Articles

Assessment of Hematologic and Non-Hematologic Toxicity in Older Cancer Patients Receiving Systemic Chemotherapy: Results from a Prospective Nationwide Registry.

Naeem Tahir, MD, Jerome H. Goldschmidt, MD, Eva Culakova, PHD, Marek S. Poniewierski, MD, MS, Debra A. Wolff, MS, PCNP, David C. Dale, MD, Jeffrey Crawford, MD, Gary H. Lyman, MD, MPH
Journal: Blood
Blood (2004) 104 (11): 3131.
https://doi.org/10.1182/blood.V104.11.3131.3131
Published: 2004
Journal Articles

Reduced Relative Dose Intensity (RDI) in Patients with Aggressive Non-Hodgkin’s Lymphoma (NHL).

David C. Dale, MD, Jerome H. Goldschmidt, MD, Jeffrey Crawford, MD, Gary H. Lyman, MD, MPH, for the ANC Study Group
Journal: Blood
Blood (2004) 104 (11): 3314.
https://doi.org/10.1182/blood.V104.11.3314.3314
Published: 2004